期刊文献+

慢性阻塞性肺疾病住院患者药物相互作用调查 被引量:7

Analysis of Drug Interactions in the Inpatients with Chronic Obstructive Pulmonary Disease
原文传递
导出
摘要 目的:了解慢性阻塞性肺疾病住院患者药物治疗及不良相互作用的发生情况。方法:从清华大学第一附属医院2006年10月~2007年2月所有被诊断为慢性阻塞性肺疾病的住院病历中随机抽取54份,调查患者的基本情况及用药情况。结果:慢性阻塞性肺疾病住院患者超过20%的时间应用8种以上药物,70%的患者存在不良相互作用。结论:该院慢性阻塞性肺疾病住院患者用药种类过多,产生不良相互作用情况较多,应采取干预措施。 OBJECTIVE: To investigate the situation of drug use and occurrence of side effects of drug interactions in the inpatients with chronic obstructive pulmonary disease (COPD) . METHODS: 54 medical charts of the inpatients in the First Affiliated Hospital of Tsinghua University diagnosed as having COPD from Oct. 2006 to Feb. 2007 were randomly collected for analyses of patients' basic information drug utilization. RESULTS: The COPD patients received more than 8 kinds of drugs simultaneously in more then 20% of their hospital days. Side effects of drug interaction occurred in 70% of them. CONCLU- SION: The study shows that the drug use in the COPD inpatients is characterized by excessive drug kinds and high incidences of drug interactions, therefore, it is urgent to take further intervention measures on drug use in COPD inpatients.
出处 《中国药房》 CAS CSCD 北大核心 2009年第8期632-634,共3页 China Pharmacy
关键词 慢性阻塞性肺疾病 住院患者 药物相互作用 合理用药 Chronic obstructive pulmonary disease Inpatients Drug interaction Rational use of drug
  • 相关文献

参考文献4

二级参考文献17

  • 1Patrono C, Coller B, FitzGerald GA, et al. Platelet - active drugs:the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J]. Chest, 2004, 126:234-264.
  • 2Pearson TA, Blair SN, Daniels SB, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee [J].Circulation, 2002, 106: 388-391.
  • 3Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low - dose aspirin in the primary prevention of cantiovascular disease in women[J].N Engl J Med, 2005, 352: 1293-1304.
  • 4Antithrombotic Trialists' Collaboration. Collaborative. Meta - analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [J]. BMJ, 2002,324:71-86.
  • 5Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST - segment elevation [J]. N Engl J Med, 2001, 345: 494-502.
  • 6Juul - Moller S, Edvardsson N, Jahnmatz B, et al. Double - blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris [J]. Lancet, 1992, 340:1421 -1425.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long - term therapy in patients undergoing percutaneous coronary intervention: the PCI - CURE study [J].Lancet, 2001, 358:527-533.
  • 8Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDBS Investigators [J]. JAMA, 1992, 268: 1292-1300.
  • 9Eikelboom iV,r, Hirsh J, Weitz JI, et al. Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].Circulation, 2002, 105: 1650-1655.
  • 10Alexander JH, Harrington RA, Turtle RH, et al. Prior aspirin use predicts worse outcomes in patients with non - ST - elevation acute coronary syndromes. PURSUIT Investigators. Platelet Ⅱb/Ⅲa in Unstable angina: Receptor Suppression Using Integrilin Therapy [ J]. Am J Cardiol, 1999, 83: 1147-1151.

共引文献5107

同被引文献46

引证文献7

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部